Relapsing-remitting multiple sclerosis is the most common form of MS, a progressive autoimmune disease in which the immune system attacks the brain and spinal cord. Washington, DC - infoZine - Three-year outcomes from an ongoing clinical trial suggest that high-dose immunosuppressive therapy followed by transplantation of a person's own blood-forming stem cells may induce sustained remission in some people with relapsing-remitting multiple sclerosis .
http://www.infozine.com/news/stories/op/storiesView/sid/60697/
http://www.infozine.com/news/stories/op/storiesView/sid/60697/
No comments:
Post a Comment